Literature DB >> 25533642

Genetic counseling content: How does it impact health behavior?

Kimberly M Kelly1, Lee Ellington2, Nancy Schoenberg3, Thomas Jackson4, Stephanie Dickinson4, Kyle Porter5, Howard Leventhal6, Michael Andrykowski3.   

Abstract

Women with hereditary breast-ovarian cancer face decisions about screening (transvaginal ultrasound, CA125, mammography, breast exams) and proactive (before cancer) or reactive (after cancer) surgery (oophorectomy, mastectomy). The content of genetic counseling and its relation to these key health behaviors is largely unexamined. Ashkenazi Jewish women (n = 78) were surveyed through the process of genetic testing and had audiorecorded counseling sessions available for Linguistic Inquiry and Word Count analysis. Proportions for participant and counselor cognitive and affective content during sessions were used as primary predictor variables in linear mixed models for change in intentions for screening and treatment and in self-reported screening. Cognitive and affective content were important predictors of behavior. Counselor cognitive content was associated with ovarian screening. An interaction effect also emerged for CA-125, such that counselor cognitive content plus participant cognitive content or counselor affective content were associated with more screening. Teasing out the factors in risk communication that impact decision-making are critical, and affect from a risk communicator can spur action, such as cancer screening.

Entities:  

Keywords:  BRCA1; BRCA2; Cancer screening; Genetic counseling; Surgery

Mesh:

Year:  2014        PMID: 25533642      PMCID: PMC4478279          DOI: 10.1007/s10865-014-9613-2

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  43 in total

1.  The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.

Authors:  C Oddoux; J P Struewing; C M Clayton; S Neuhausen; L C Brody; M Kaback; B Haas; L Norton; P Borgen; S Jhanwar; D Goldgar; H Ostrer; K Offit
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

Review 2.  Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.

Authors:  P Tonin; B Weber; K Offit; F Couch; T R Rebbeck; S Neuhausen; A K Godwin; M Daly; J Wagner-Costalos; D Berman; G Grana; E Fox; M F Kane; R D Kolodner; M Krainer; D A Haber; J P Struewing; E Warner; B Rosen; C Lerman; B Peshkin; L Norton; O Serova; W D Foulkes; J E Garber
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

Review 3.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.

Authors:  W Burke; M Daly; J Garber; J Botkin; M J Kahn; P Lynch; A McTiernan; K Offit; J Perlman; G Petersen; E Thomson; C Varricchio
Journal:  JAMA       Date:  1997-03-26       Impact factor: 56.272

Review 4.  Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation.

Authors:  Sara Wainberg; Janice Husted
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-12       Impact factor: 4.254

5.  Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors.

Authors:  Suzanne M Miller; Pagona Roussi; Mary B Daly; Joanne S Buzaglo; Kerry Sherman; Andrew K Godwin; Andrew Balshem; Margaret E Atchison
Journal:  Health Educ Behav       Date:  2005-10

6.  Early detection of breast and ovarian cancer in families with BRCA mutations.

Authors:  H F A Vasen; E Tesfay; H Boonstra; M J E Mourits; E Rutgers; R Verheyen; J Oosterwijk; L Beex
Journal:  Eur J Cancer       Date:  2005-01-11       Impact factor: 9.162

7.  Communication analysis of BRCA1 genetic counseling.

Authors:  Lee Ellington; Debra Roter; William N Dudley; Bonnie J Baty; Renn Upchurch; Susan Larson; Jean E Wylie; Ken R Smith; Jeffrey R Botkin
Journal:  J Genet Couns       Date:  2005-10       Impact factor: 2.537

8.  The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations.

Authors:  Kimberly Kelly; Howard Leventhal; Michael Andrykowski; Deborah Toppmeyer; Judie Much; James Dermody; Monica Marvin; Jill Baran; Marvin Schwalb
Journal:  J Genet Couns       Date:  2004-06       Impact factor: 2.537

9.  Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.

Authors:  L C Hartmann; D J Schaid; J E Woods; T P Crotty; J L Myers; P G Arnold; P M Petty; T A Sellers; J L Johnson; S K McDonnell; M H Frost; R B Jenkins
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

10.  Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.

Authors:  M G FitzGerald; D J MacDonald; M Krainer; I Hoover; E O'Neil; H Unsal; S Silva-Arrieto; D M Finkelstein; P Beer-Romero; C Englert; D C Sgroi; B L Smith; J W Younger; J E Garber; R B Duda; K A Mayzel; K J Isselbacher; S H Friend; D A Haber
Journal:  N Engl J Med       Date:  1996-01-18       Impact factor: 91.245

View more
  6 in total

1.  Current directions in behavioral medicine research on genetic testing for disease susceptibility: introduction to the special section.

Authors:  Kerry A Sherman; Linda D Cameron
Journal:  J Behav Med       Date:  2015-10

2.  Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations.

Authors:  Ishveen Chopra; Kimberly M Kelly
Journal:  J Health Commun       Date:  2017-01-23

3.  Impact of Genetic Counseling and Testing on Altruistic Motivations to Test for BRCA1/2: a Longitudinal Study.

Authors:  Rahul Garg; Joseph Vogelgesang; Kimberly Kelly
Journal:  J Genet Couns       Date:  2015-11-18       Impact factor: 2.537

4.  Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode.

Authors:  Laurie E Steffen; Ruofei Du; Amanda Gammon; Jeanne S Mandelblatt; Wendy K Kohlmann; Ji-Hyun Lee; Saundra S Buys; Antoinette M Stroup; Rebecca A Campo; Kristina G Flores; Belinda Vicuña; Marc D Schwartz; Anita Y Kinney
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-09-29       Impact factor: 4.254

5.  Familial breast cancer: Genetic counseling over time, including patients´ expectations and initiators considering the Angelina Jolie effect.

Authors:  Christina Evers; Christine Fischer; Nicola Dikow; Sarah Schott
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

6.  Genetic counselor implicit bias and its effects on cognitive and affective exchanges in racially discordant simulations.

Authors:  Chenery L Lowe; Mary Catherine Beach; Debra L Roter
Journal:  J Genet Couns       Date:  2020-03-06       Impact factor: 2.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.